Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Applied Molecular Transport Inc. (AMTI : NSDQ)

• Company Description    Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. It design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic and other diseases. The company's lead product candidate consist AMT-101, which is in clinical stage. Applied Molecular Transport Inc. is based in Calif. Number of Employees: 79

• Price / Volume Information    Yesterday's Closing Price: $0.27 Daily Weekly Monthly 20 Day Moving Average: 101,189 shares Shares Outstanding: 39.34 (millions) Market Capitalization: $10.50 (millions) Beta: 1.98 52 Week High: $4.17 52 Week Low: $0.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.69% -1.20% 12 Week -53.26% -56.62% Year To Date -36.43% -42.17%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 450 East Jamie Court - South San Francisco,CA 94080 USA ph: 650-392-0420 fax: - asantos@wheelhouselsa.com http://www.appliedmt.com

• General Corporate Information    Officers Tahir Mahmood - Co-Founder; Chief Executive Officer and Director Brandon Hants - Chief Financial Officer Charlene Banard - Director David Lamond - Director John Smither - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 03824M109 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/23 Next Expected EPS Date: 08/03/23 Share - Related Items Shares Outstanding: 39.34 Most Recent Split Date: (:1) Beta: 1.98 Market Capitalization: $10.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.23 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.38 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 52.33% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/23

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.29 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 35.45% vs. Previous Quarter: -22.41% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/23 - -163.54 12/31/22 - -138.50 09/30/22 - -114.57 ROA 03/31/23 - -96.55 12/31/22 - -90.07 09/30/22 - -80.25 Current Ratio 03/31/23 - 2.75 12/31/22 - 4.24 09/30/22 - 5.68 Quick Ratio 03/31/23 - 2.75 12/31/22 - 4.24 09/30/22 - 5.68 Operating Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Net Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Pre-Tax Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Book Value 03/31/23 - 0.92 12/31/22 - 1.56 09/30/22 - 2.02 Inventory Turnover 03/31/23 - - 12/31/22 - - 09/30/22 - - Debt-to-Equity 03/31/23 - 0.00 12/31/22 - 0.00 09/30/22 - 0.00 Debt-to-Capital 03/31/23 - 0.31 12/31/22 - 0.08 09/30/22 - 0.08

Powered by Zacks Investment Research ©